JPH03244381A - New restriction enzyme and its production - Google Patents
New restriction enzyme and its productionInfo
- Publication number
- JPH03244381A JPH03244381A JP2041512A JP4151290A JPH03244381A JP H03244381 A JPH03244381 A JP H03244381A JP 2041512 A JP2041512 A JP 2041512A JP 4151290 A JP4151290 A JP 4151290A JP H03244381 A JPH03244381 A JP H03244381A
- Authority
- JP
- Japan
- Prior art keywords
- restriction enzyme
- ccoi
- stable
- clostridium
- genus clostridium
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 108091008146 restriction endonucleases Proteins 0.000 title claims abstract description 49
- 238000004519 manufacturing process Methods 0.000 title claims description 7
- 102000053602 DNA Human genes 0.000 claims abstract description 21
- 108020004414 DNA Proteins 0.000 claims abstract description 21
- 238000000034 method Methods 0.000 claims abstract description 13
- 241000193403 Clostridium Species 0.000 claims abstract description 9
- 239000000284 extract Substances 0.000 claims abstract description 7
- 241000186560 Blautia coccoides Species 0.000 claims abstract description 5
- 230000002255 enzymatic effect Effects 0.000 claims abstract description 5
- 239000000126 substance Substances 0.000 claims abstract description 4
- 239000000758 substrate Substances 0.000 claims abstract description 4
- 235000015097 nutrients Nutrition 0.000 claims abstract description 3
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 claims description 22
- 241000894006 Bacteria Species 0.000 claims description 11
- 239000011780 sodium chloride Substances 0.000 claims description 11
- 238000002523 gelfiltration Methods 0.000 claims description 4
- 150000003839 salts Chemical class 0.000 claims description 3
- 238000010438 heat treatment Methods 0.000 claims description 2
- NYHBQMYGNKIUIF-UUOKFMHZSA-N Guanosine Chemical compound C1=NC=2C(=O)NC(N)=NC=2N1[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O NYHBQMYGNKIUIF-UUOKFMHZSA-N 0.000 claims 2
- UHDGCWIWMRVCDJ-UHFFFAOYSA-N 1-beta-D-Xylofuranosyl-NH-Cytosine Natural products O=C1N=C(N)C=CN1C1C(O)C(O)C(CO)O1 UHDGCWIWMRVCDJ-UHFFFAOYSA-N 0.000 claims 1
- MIKUYHXYGGJMLM-GIMIYPNGSA-N Crotonoside Natural products C1=NC2=C(N)NC(=O)N=C2N1[C@H]1O[C@@H](CO)[C@H](O)[C@@H]1O MIKUYHXYGGJMLM-GIMIYPNGSA-N 0.000 claims 1
- UHDGCWIWMRVCDJ-PSQAKQOGSA-N Cytidine Natural products O=C1N=C(N)C=CN1[C@@H]1[C@@H](O)[C@@H](O)[C@H](CO)O1 UHDGCWIWMRVCDJ-PSQAKQOGSA-N 0.000 claims 1
- NYHBQMYGNKIUIF-UHFFFAOYSA-N D-guanosine Natural products C1=2NC(N)=NC(=O)C=2N=CN1C1OC(CO)C(O)C1O NYHBQMYGNKIUIF-UHFFFAOYSA-N 0.000 claims 1
- UHDGCWIWMRVCDJ-ZAKLUEHWSA-N cytidine Chemical compound O=C1N=C(N)C=CN1[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O1 UHDGCWIWMRVCDJ-ZAKLUEHWSA-N 0.000 claims 1
- 229940029575 guanosine Drugs 0.000 claims 1
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 abstract description 4
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 abstract description 4
- 238000005119 centrifugation Methods 0.000 abstract description 4
- 239000008103 glucose Substances 0.000 abstract description 4
- 238000009776 industrial production Methods 0.000 abstract description 4
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 abstract description 3
- 239000001888 Peptone Substances 0.000 abstract description 3
- 108010080698 Peptones Proteins 0.000 abstract description 3
- 229910052799 carbon Inorganic materials 0.000 abstract description 3
- 244000005700 microbiome Species 0.000 abstract description 3
- 235000019319 peptone Nutrition 0.000 abstract description 3
- 238000004587 chromatography analysis Methods 0.000 abstract description 2
- 238000007796 conventional method Methods 0.000 abstract description 2
- 229910052757 nitrogen Inorganic materials 0.000 abstract description 2
- 239000001963 growth medium Substances 0.000 abstract 2
- 230000000813 microbial effect Effects 0.000 abstract 2
- 238000012258 culturing Methods 0.000 abstract 1
- 238000005342 ion exchange Methods 0.000 abstract 1
- 238000009210 therapy by ultrasound Methods 0.000 abstract 1
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 15
- 108090000790 Enzymes Proteins 0.000 description 10
- 102000004190 Enzymes Human genes 0.000 description 10
- 238000006243 chemical reaction Methods 0.000 description 7
- 230000000694 effects Effects 0.000 description 7
- 241000588724 Escherichia coli Species 0.000 description 6
- TWRXJAOTZQYOKJ-UHFFFAOYSA-L Magnesium chloride Chemical compound [Mg+2].[Cl-].[Cl-] TWRXJAOTZQYOKJ-UHFFFAOYSA-L 0.000 description 6
- 230000001580 bacterial effect Effects 0.000 description 5
- 239000012634 fragment Substances 0.000 description 5
- 239000000243 solution Substances 0.000 description 5
- 108090000623 proteins and genes Proteins 0.000 description 4
- DGVVWUTYPXICAM-UHFFFAOYSA-N β‐Mercaptoethanol Chemical compound OCCS DGVVWUTYPXICAM-UHFFFAOYSA-N 0.000 description 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- 229910019142 PO4 Inorganic materials 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 239000002253 acid Substances 0.000 description 3
- 229940041514 candida albicans extract Drugs 0.000 description 3
- 238000012136 culture method Methods 0.000 description 3
- 238000004255 ion exchange chromatography Methods 0.000 description 3
- 229910001629 magnesium chloride Inorganic materials 0.000 description 3
- 239000002609 medium Substances 0.000 description 3
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 3
- 239000010452 phosphate Substances 0.000 description 3
- 238000000746 purification Methods 0.000 description 3
- 239000002023 wood Substances 0.000 description 3
- 239000012138 yeast extract Substances 0.000 description 3
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 2
- SRBFZHDQGSBBOR-IOVATXLUSA-N D-xylopyranose Chemical compound O[C@@H]1COC(O)[C@H](O)[C@H]1O SRBFZHDQGSBBOR-IOVATXLUSA-N 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- SIKJAQJRHWYJAI-UHFFFAOYSA-N Indole Chemical compound C1=CC=C2NC=CC2=C1 SIKJAQJRHWYJAI-UHFFFAOYSA-N 0.000 description 2
- 229930195725 Mannitol Natural products 0.000 description 2
- 238000001042 affinity chromatography Methods 0.000 description 2
- PYMYPHUHKUWMLA-UHFFFAOYSA-N arabinose Natural products OCC(O)C(O)C(O)C=O PYMYPHUHKUWMLA-UHFFFAOYSA-N 0.000 description 2
- SRBFZHDQGSBBOR-UHFFFAOYSA-N beta-D-Pyranose-Lyxose Natural products OC1COC(O)C(O)C1O SRBFZHDQGSBBOR-UHFFFAOYSA-N 0.000 description 2
- 238000003776 cleavage reaction Methods 0.000 description 2
- 238000010828 elution Methods 0.000 description 2
- 238000006911 enzymatic reaction Methods 0.000 description 2
- 239000011521 glass Substances 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 239000000594 mannitol Substances 0.000 description 2
- 235000010355 mannitol Nutrition 0.000 description 2
- 239000002773 nucleotide Substances 0.000 description 2
- 125000003729 nucleotide group Chemical group 0.000 description 2
- 230000001766 physiological effect Effects 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 230000002285 radioactive effect Effects 0.000 description 2
- 230000007017 scission Effects 0.000 description 2
- KDYFGRWQOYBRFD-UHFFFAOYSA-N succinic acid Chemical compound OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 2
- LWIHDJKSTIGBAC-UHFFFAOYSA-K tripotassium phosphate Chemical compound [K+].[K+].[K+].[O-]P([O-])([O-])=O LWIHDJKSTIGBAC-UHFFFAOYSA-K 0.000 description 2
- HDTRYLNUVZCQOY-UHFFFAOYSA-N α-D-glucopyranosyl-α-D-glucopyranoside Natural products OC1C(O)C(O)C(CO)OC1OC1C(O)C(O)C(O)C(CO)O1 HDTRYLNUVZCQOY-UHFFFAOYSA-N 0.000 description 1
- QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 1
- ZKHQWZAMYRWXGA-KQYNXXCUSA-J ATP(4-) Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](COP([O-])(=O)OP([O-])(=O)OP([O-])([O-])=O)[C@@H](O)[C@H]1O ZKHQWZAMYRWXGA-KQYNXXCUSA-J 0.000 description 1
- ZKHQWZAMYRWXGA-UHFFFAOYSA-N Adenosine triphosphate Natural products C1=NC=2C(N)=NC=NC=2N1C1OC(COP(O)(=O)OP(O)(=O)OP(O)(O)=O)C(O)C1O ZKHQWZAMYRWXGA-UHFFFAOYSA-N 0.000 description 1
- 102000002260 Alkaline Phosphatase Human genes 0.000 description 1
- 108020004774 Alkaline Phosphatase Proteins 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 1
- GUBGYTABKSRVRQ-CUHNMECISA-N D-Cellobiose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-CUHNMECISA-N 0.000 description 1
- SHZGCJCMOBCMKK-UHFFFAOYSA-N D-mannomethylose Natural products CC1OC(O)C(O)C(O)C1O SHZGCJCMOBCMKK-UHFFFAOYSA-N 0.000 description 1
- WQZGKKKJIJFFOK-QTVWNMPRSA-N D-mannopyranose Chemical compound OC[C@H]1OC(O)[C@@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-QTVWNMPRSA-N 0.000 description 1
- QXNVGIXVLWOKEQ-UHFFFAOYSA-N Disodium Chemical compound [Na][Na] QXNVGIXVLWOKEQ-UHFFFAOYSA-N 0.000 description 1
- 108010042407 Endonucleases Proteins 0.000 description 1
- 102000004533 Endonucleases Human genes 0.000 description 1
- 239000004386 Erythritol Substances 0.000 description 1
- UNXHWFMMPAWVPI-UHFFFAOYSA-N Erythritol Natural products OCC(O)C(O)CO UNXHWFMMPAWVPI-UHFFFAOYSA-N 0.000 description 1
- 241001524679 Escherichia virus M13 Species 0.000 description 1
- 241000702315 Escherichia virus phiX174 Species 0.000 description 1
- 229930091371 Fructose Natural products 0.000 description 1
- 239000005715 Fructose Substances 0.000 description 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- 206010018910 Haemolysis Diseases 0.000 description 1
- SQUHHTBVTRBESD-UHFFFAOYSA-N Hexa-Ac-myo-Inositol Natural products CC(=O)OC1C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C1OC(C)=O SQUHHTBVTRBESD-UHFFFAOYSA-N 0.000 description 1
- 208000026350 Inborn Genetic disease Diseases 0.000 description 1
- SHZGCJCMOBCMKK-JFNONXLTSA-N L-rhamnopyranose Chemical compound C[C@@H]1OC(O)[C@H](O)[C@H](O)[C@H]1O SHZGCJCMOBCMKK-JFNONXLTSA-N 0.000 description 1
- PNNNRSAQSRJVSB-UHFFFAOYSA-N L-rhamnose Natural products CC(O)C(O)C(O)C(O)C=O PNNNRSAQSRJVSB-UHFFFAOYSA-N 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- 241000970318 Lechevalieria aerocolonigenes Species 0.000 description 1
- 229910002651 NO3 Inorganic materials 0.000 description 1
- NHNBFGGVMKEFGY-UHFFFAOYSA-N Nitrate Chemical compound [O-][N+]([O-])=O NHNBFGGVMKEFGY-UHFFFAOYSA-N 0.000 description 1
- 102000015439 Phospholipases Human genes 0.000 description 1
- 108010064785 Phospholipases Proteins 0.000 description 1
- 102000004160 Phosphoric Monoester Hydrolases Human genes 0.000 description 1
- 108090000608 Phosphoric Monoester Hydrolases Proteins 0.000 description 1
- 108010021757 Polynucleotide 5'-Hydroxyl-Kinase Proteins 0.000 description 1
- 102000008422 Polynucleotide 5'-hydroxyl-kinase Human genes 0.000 description 1
- MUPFEKGTMRGPLJ-RMMQSMQOSA-N Raffinose Natural products O(C[C@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@@H](O[C@@]2(CO)[C@H](O)[C@@H](O)[C@@H](CO)O2)O1)[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 MUPFEKGTMRGPLJ-RMMQSMQOSA-N 0.000 description 1
- 238000012300 Sequence Analysis Methods 0.000 description 1
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 description 1
- 229910000831 Steel Inorganic materials 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 108700005078 Synthetic Genes Proteins 0.000 description 1
- HDTRYLNUVZCQOY-WSWWMNSNSA-N Trehalose Natural products O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-WSWWMNSNSA-N 0.000 description 1
- MUPFEKGTMRGPLJ-UHFFFAOYSA-N UNPD196149 Natural products OC1C(O)C(CO)OC1(CO)OC1C(O)C(O)C(O)C(COC2C(C(O)C(O)C(CO)O2)O)O1 MUPFEKGTMRGPLJ-UHFFFAOYSA-N 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 238000000246 agarose gel electrophoresis Methods 0.000 description 1
- HDTRYLNUVZCQOY-LIZSDCNHSA-N alpha,alpha-trehalose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-LIZSDCNHSA-N 0.000 description 1
- 235000001014 amino acid Nutrition 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- PYMYPHUHKUWMLA-WDCZJNDASA-N arabinose Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)C=O PYMYPHUHKUWMLA-WDCZJNDASA-N 0.000 description 1
- DLRVVLDZNNYCBX-ZZFZYMBESA-N beta-melibiose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1OC[C@@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@H](O)O1 DLRVVLDZNNYCBX-ZZFZYMBESA-N 0.000 description 1
- 239000012503 blood component Substances 0.000 description 1
- UDSAIICHUKSCKT-UHFFFAOYSA-N bromophenol blue Chemical compound C1=C(Br)C(O)=C(Br)C=C1C1(C=2C=C(Br)C(O)=C(Br)C=2)C2=CC=CC=C2S(=O)(=O)O1 UDSAIICHUKSCKT-UHFFFAOYSA-N 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 description 1
- 235000018417 cysteine Nutrition 0.000 description 1
- 230000000593 degrading effect Effects 0.000 description 1
- 235000019414 erythritol Nutrition 0.000 description 1
- UNXHWFMMPAWVPI-ZXZARUISSA-N erythritol Chemical compound OC[C@H](O)[C@H](O)CO UNXHWFMMPAWVPI-ZXZARUISSA-N 0.000 description 1
- 229940009714 erythritol Drugs 0.000 description 1
- ZMMJGEGLRURXTF-UHFFFAOYSA-N ethidium bromide Chemical compound [Br-].C12=CC(N)=CC=C2C2=CC=C(N)C=C2[N+](CC)=C1C1=CC=CC=C1 ZMMJGEGLRURXTF-UHFFFAOYSA-N 0.000 description 1
- 229960005542 ethidium bromide Drugs 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 210000003608 fece Anatomy 0.000 description 1
- 238000000855 fermentation Methods 0.000 description 1
- 230000004151 fermentation Effects 0.000 description 1
- 229930182830 galactose Natural products 0.000 description 1
- 238000001641 gel filtration chromatography Methods 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 238000010359 gene isolation Methods 0.000 description 1
- 208000016361 genetic disease Diseases 0.000 description 1
- 238000010353 genetic engineering Methods 0.000 description 1
- 239000006481 glucose medium Substances 0.000 description 1
- 238000004128 high performance liquid chromatography Methods 0.000 description 1
- PZOUSPYUWWUPPK-UHFFFAOYSA-N indole Natural products CC1=CC=CC2=C1C=CN2 PZOUSPYUWWUPPK-UHFFFAOYSA-N 0.000 description 1
- RKJUIXBNRJVNHR-UHFFFAOYSA-N indolenine Natural products C1=CC=C2CC=NC2=C1 RKJUIXBNRJVNHR-UHFFFAOYSA-N 0.000 description 1
- CDAISMWEOUEBRE-GPIVLXJGSA-N inositol Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@H](O)[C@@H]1O CDAISMWEOUEBRE-GPIVLXJGSA-N 0.000 description 1
- 229960000367 inositol Drugs 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 235000019626 lipase activity Nutrition 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 239000013612 plasmid Substances 0.000 description 1
- 238000002264 polyacrylamide gel electrophoresis Methods 0.000 description 1
- 229910000160 potassium phosphate Inorganic materials 0.000 description 1
- 235000011009 potassium phosphates Nutrition 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- MUPFEKGTMRGPLJ-ZQSKZDJDSA-N raffinose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO[C@@H]2[C@@H]([C@@H](O)[C@@H](O)[C@@H](CO)O2)O)O1 MUPFEKGTMRGPLJ-ZQSKZDJDSA-N 0.000 description 1
- CDAISMWEOUEBRE-UHFFFAOYSA-N scyllo-inosotol Natural products OC1C(O)C(O)C(O)C(O)C1O CDAISMWEOUEBRE-UHFFFAOYSA-N 0.000 description 1
- 239000010959 steel Substances 0.000 description 1
- 239000012089 stop solution Substances 0.000 description 1
- 239000001384 succinic acid Substances 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 235000000346 sugar Nutrition 0.000 description 1
- 150000008163 sugars Chemical class 0.000 description 1
- 238000002525 ultrasonication Methods 0.000 description 1
- 241001446247 uncultured actinomycete Species 0.000 description 1
- 241001148471 unidentified anaerobic bacterium Species 0.000 description 1
Landscapes
- Enzymes And Modification Thereof (AREA)
Abstract
Description
【発明の詳細な説明】 [産業上の利用分野] 本発明は新規な制限酵素及びその製造方法に関する。[Detailed description of the invention] [Industrial application field] The present invention relates to a novel restriction enzyme and a method for producing the same.
[従来の技術]
制限酵素とはデオキシリボ核酸(DNA)上の成る特定
の塩基配列を認識し、この配列内または近傍の2本鎖を
切断するエンドヌクレアーゼである。[Prior Art] Restriction enzymes are endonucleases that recognize a specific base sequence on deoxyribonucleic acid (DNA) and cleave double strands within or near this sequence.
この制限酵素は酵素活性に高い基質特異性と再現性を有
しており、また遺伝子の単離、塩基配列の解析や蛋白質
の構造解析をはじめ、遺伝物質の大量生産などの遺伝子
操作を行う上で不可欠な酵素である。This restriction enzyme has high substrate specificity and reproducibility in its enzymatic activity, and is also useful for genetic manipulation such as gene isolation, base sequence analysis, protein structure analysis, and mass production of genetic materials. It is an essential enzyme.
また、今後の遺伝病の解明や治療、遺伝子の人工変換等
に重要な産業的意義を有する試薬でもある。It is also a reagent that will have important industrial significance in future elucidation and treatment of genetic diseases, artificial gene conversion, etc.
制限酵素は種々の微生物より単離されており、その認識
する塩基配列、切断様式により現在までに約100種類
が知られているが、これら制限酵素も理論上考えられる
種類の酵素の半分はどしか発見されていない。Restriction enzymes have been isolated from various microorganisms, and about 100 types are known to date, depending on their recognition base sequences and cleavage modes. only been discovered.
[本発明の目的]
本発明者等はイ1効な制限酵素の開発を目的として多数
の制限酵素生産菌の研究を行なってきた。[Object of the present invention] The present inventors have conducted research on a large number of restriction enzyme-producing bacteria with the aim of developing effective restriction enzymes.
その結果、クロストリジウム属に属する菌が、既存の放
線菌Nocardia aero−colonigen
es由来の制限酵素Naelのアイソシソマーを生産し
ていることを突き止めた。As a result, bacteria belonging to the genus Clostridium were found to be different from the existing actinomycete Nocardia aero-colonigen.
It was discovered that isosisomers of the restriction enzyme Nael derived from es were produced.
この菌は短時間の培養で制限酵素の生産性が高い、しか
も本菌の生産する制限酵素Cco Iは熱やpHに対し
て高度に安定性があることを見出し、本発明の完成に至
った。すなわち、本発明は従来使用されてきた制限酵素
Naelに比べ、より幅広い温度安定性とp)I安定性
を有する制限酵素CcoI及びその工業的生産方法を提
供することにある。It was discovered that this bacterium has a high productivity of restriction enzymes even when cultured for a short period of time, and that the restriction enzyme Cco I produced by this bacterium is highly stable against heat and pH, leading to the completion of the present invention. . That is, the present invention provides a restriction enzyme CcoI which has a wider range of temperature stability and p)I stability than the conventionally used restriction enzyme Nael, and an industrial production method thereof.
E問題点を解決する為の手段]
本発明中の第1発明は次の酵素化学的諸性質を有する新
規制限酵素CcoIに関するものである。Means for Solving Problem E] The first invention of the present invention relates to a novel restriction enzyme CcoI having the following enzymatic chemical properties.
(a)作用及び基質特異性 制限酵素Cco Iは2木釦デオキシリボ核酸中の↓ ↑ という塩基配列を認識し、矢印で切断する酵素である。(a) Action and substrate specificity Restriction enzyme Cco I is ↓ in 2Kibutsu deoxyribonucleic acid ↑ It is an enzyme that recognizes this base sequence and cuts it with an arrow.
制限酵素CcoIの認識部位の決定のため、大腸菌ファ
ージ入 DNA、動物ウィルスAd2 IINA 、大
腸菌ファージφX174 RF DNA 、大腸菌ファ
ージ813 mp18 RF DNA 、動物つ4 ル
スSV40 DNA、大腸菌プラスミFpBR322D
NAの各DNAの切断数を調へた。To determine the recognition site of the restriction enzyme CcoI, E. coli phage DNA, animal virus Ad2 IINA, E. coli phage φX174 RF DNA, E. coli phage 813 mp18 RF DNA, animal virus SV40 DNA, E. coli plasmid FpBR322D
The number of cleavages of each DNA in NA was determined.
ソノ結果、入DNA、SV40 DNA、M2ODNA
を1fll所、Ad2 DNAを13箇所、pBR32
2DNAを4箇所切断した。Sono result, input DNA, SV40 DNA, M2OD DNA
1 full site, 13 sites of Ad2 DNA, pBR32
2 DNA was cut at 4 locations.
これをファー、クスノデータ(Gene、Vol、10
゜P−3? I 、 1980年)に照らし合わせたと
ころ、木酵素は5’−GCCGGC−3’を認識切断す
ることが示された。これは、制限酵素Nael(Kes
sler、[1:、 andHoltke、Hl、 、
Gene、Vol、4?、P−1−153,1988年
)の認識塩基配タリであった。This is fur, Kusuno data (Gene, Vol, 10
゜P-3? I, 1980), wood enzymes were shown to recognize and cleave 5'-GCCGGC-3'. This is the restriction enzyme Nael (Kes
sler, [1:, and Holtke, Hl, ,
Gene, Vol. 4? , P-1-153, 1988).
そこ−C1SV40 []NAヲ用イ、制F[[素Gc
oL!=制限酵素Naelのタブルタイゼ゛ツションを
試みたところ、切断片に変化はなく、制限酵素GcoI
は制限酵素Naelのアイソシソマーであることが確認
された。So-C1SV40 []NAwo use, control F[[elementary Gc
oL! = When we tried tabultization with the restriction enzyme Nael, there was no change in the cut fragment, and the restriction enzyme GcoI
was confirmed to be an isosisomer of the restriction enzyme Nael.
νj断点の決定は次の方法で行った。The νj cutoff point was determined by the following method.
まず、制限酵素(:co lで大腸菌ファージM13
mp+a RF DNAを切断し、切断末端のリン酸を
アルカリフォスファターゼで除いた。First, extract Escherichia coli phage M13 with restriction enzyme (:col).
The mp+a RF DNA was cut, and the phosphate at the cut end was removed with alkaline phosphatase.
次にポリヌクレオチドカイネース及び
[γ−32P]アデノシン三リン酸を用いて、IINA
断片の5′末端に放射性リン酸を付加した。Then, using polynucleotide kinase and [γ-32P]adenosine triphosphate, IINA
Radioactive phosphate was added to the 5' end of the fragment.
この放射性リン酸を付カーしたDNA断片を制限酵素B
be Iで切断し、新たに生成された断片の内388b
p(ベースペアー)をポリアクリルアミドゲル電気泳動
で分離、分取した。This DNA fragment with radioactive phosphate is digested with restriction enzyme B.
Among the newly generated fragments cut with be I, 388b
p (base pair) was separated and fractionated by polyacrylamide gel electrophoresis.
この断片をマクサム・キルノヘート法によりその5゛末
端からの塩基配列を調べたところ、これらの実験から得
られた制限酵素CcoIは、↓
↑
という塩基配列を認識し、矢印の位置で切断していると
判明した。When this fragment was examined for its nucleotide sequence from the 5' end using the Maxam-Kirnoheit method, the restriction enzyme CcoI obtained from these experiments recognized the nucleotide sequence ↓ ↑ and cut it at the position indicated by the arrow. It turned out to be.
(b)酵素反応の至適条件及び酵素の安定性至適pH:
制限酵素Cco Iの至適pHは8.0であった。(b) Optimal conditions for enzyme reaction and optimal pH for enzyme stability:
The optimum pH of the restriction enzyme Cco I was 8.0.
安定pH:制限酵素CcoIは4℃24時間の処理にお
いて、pH5,0〜1O00の間で100%の活性を維
持していた。Stable pH: Restriction enzyme CcoI maintained 100% activity at pH 5.0 to 1000 during treatment at 4°C for 24 hours.
至適温度 二制限酵素CcoIの至適温度は45℃であった。Optimal temperature The optimum temperature for the double restriction enzyme CcoI was 45°C.
安定温度
=70℃、5分間の加熱でも100%の活性を維持して
いた。100% activity was maintained even after heating for 5 minutes at a stable temperature of 70°C.
安定塩濃度:塩化ナトリウム濃度50mM〜loomM
で安定に活性を示した。至適塩濃
度は50mMであった。Stable salt concentration: Sodium chloride concentration 50mM to loomM
showed stable activity. The optimal salt concentration was 50mM.
(c)分子tic : TSKgel G3000S
W Glass (東ソー■製)を用いたゲルろ過法で
62,000であった・
本発明中の第2発明は、クロストリジウム属に属する制
限酵素CcoI生産菌を栄養培地で培養し、培養物より
制限酵素CcoIを採取することを特徴とするものであ
る。(c) Molecular tic: TSKgel G3000S
62,000 by the gel filtration method using W Glass (manufactured by Tosoh).The second invention of the present invention is to culture a restriction enzyme CcoI-producing bacterium belonging to the genus Clostridium in a nutrient medium, and to obtain restriction enzymes from the culture. This method is characterized by collecting the enzyme CcoI.
本発明で使用する微生物はクロストリジウム属に属する
CcoI生産菌であればいずれでも良いが、例えば人糞
中より分離されたクロストリジウム コツコイデスB−
2(微工研菌条寄第11238号)が好適である。The microorganism used in the present invention may be any CcoI-producing bacterium belonging to the genus Clostridium, but for example, Clostridium coccoides B- isolated from human feces may be used.
2 (Feiko Kenboku Joyori No. 11238) is suitable.
木菌は以下に示す生理学的性質を有していた。The wood fungus had the following physiological properties.
1偏性嫌気性菌
2偏在性芽胞形威 +、ダラム陽性短桿菌(0,6〜1
.OXo、8〜3.0141)3運動性
硝酸塩生成
インドール生成
ゼラチン液化
レシチナーゼ活性
リパーゼ活性
溶血反応
4コハク酸・酢酸発酵
ペプトン、酵母エキス、フィルデス液、グルコース培地
による
5炭素源同化性
アラビノース + キシロース +ラムノース
+ ンルポース +リポース + グルコース
+マンノース + フルクトース +ガラク
トース + シュークロース +マンニトール +
セロビオース +ラクトース +、トレハロース
+メリビオース +、ラフィノース +メレチトー
ス +、ンルヒトール +イノシトール +、グリセ
ロール
マンニトール +、エリスリトール
本菌は以上の生理学的性質から「腸内菌の世界・嫌気性
菌の分離と同定」 (光岡知足著)によりクロストリジ
ウム・コッコイデス(clostridium coc
coides)と同定された。1. Obligate anaerobes 2. Obligate spore-forming bacteria +, Durham-positive short rods (0.6-1
.. OXo, 8-3.0141) 3 Motile nitrate production Indole production Gelatin liquefaction Lecithinase activity Lipase activity Hemolytic reaction 4 Succinic acid/acetic acid fermentation Peptone, yeast extract, Fildes' solution, glucose medium 5 Carbon sources Assimilable Arabinose + Xylose + Rhamnose
+ Nluportose + Repose + Glucose + Mannose + Fructose + Galactose + Sucrose + Mannitol +
Cellobiose + lactose +, trehalose
+ melibiose +, raffinose + meletitose +, nluchtol + inositol +, glycerol mannitol +, erythritol Based on the above physiological properties, this bacterium was classified as Clostridium in “The World of Intestinal Bacteria: Isolation and Identification of Anaerobic Bacteria” (written by Tomozoku Mitsuoka).・Clostridium coc
coides).
培養法に制限はなく、通常行われるクロストリジウム属
細菌の培養法で増殖可能であるものなら何でもよい。There are no restrictions on the culture method, and any culture method that can be grown using a commonly used culture method for Clostridium bacteria may be used.
例えば、炭素源としてはグルコース、ンユークロースな
どの糖類、及び窒素源としてペプトン、アミノ酸、酵母
エキスなど、その他の無機NTnとして塩化ナトリウム
や塩化マグネシウム、リン酸カリウムなどを用いる。For example, sugars such as glucose and euclose are used as carbon sources, peptone, amino acids, yeast extract, etc. are used as nitrogen sources, and sodium chloride, magnesium chloride, potassium phosphate, etc. are used as other inorganic NTn.
また、血液成分を数%加えることにより成育がよくなる
。Growth is also improved by adding a few percent of blood components.
木酵素の抽出、精製は一般の制限酵素精製法に従った方
法で行なえる。Extraction and purification of wood enzymes can be carried out according to general restriction enzyme purification methods.
すなわち、培養菌体は常法に従って集菌し、超音波処理
などの方法により菌体を破砕する。That is, cultured bacterial cells are collected according to a conventional method, and the bacterial cells are disrupted by a method such as ultrasonication.
破砕後、遠心分離などの方法で無細胞抽出液を得る。After disruption, a cell-free extract is obtained by a method such as centrifugation.
この抽出液をイオン交換クロマトグラフィー法・ゲルろ
過法、アフィニティークロマトグラフィー法などのクロ
マトグラフィー法の組合わせにより精製を行い、制限酵
素CcoIを得る。This extract is purified by a combination of chromatography methods such as ion exchange chromatography, gel filtration, and affinity chromatography to obtain the restriction enzyme CcoI.
CcOIの活性測定は次の通り行った。The activity of CcOI was measured as follows.
10mM ト リス塩酸、pH7,5,7mM 2−
メルカプトエタノール、71M塩化マグネシウム、50
mM塩化ナトリウム、1μg入DNAからなる反応系に
、酵素を加えて全量を50ρ℃とし、37℃で1時間反
応させた。10mM Tris-HCl, pH 7,5,7mM 2-
Mercaptoethanol, 71M magnesium chloride, 50
The enzyme was added to a reaction system consisting of mM sodium chloride and 1 µg of DNA to bring the total volume to 50 ρ°C, and the reaction was carried out at 37°C for 1 hour.
反応液に1$ S[]S (ドデシル硫酸ナトリウム)
、 50%グIJ −1= O−ル、0.1$BPB
(ブロモフェノールブルー)からなる酵素反応停止液を
511β加えて反応を停止させた。Add 1$ S[]S (sodium dodecyl sulfate) to the reaction solution.
, 50%G IJ -1= O-L, 0.1$BPB
The reaction was stopped by adding 511β of an enzyme reaction stop solution consisting of (bromophenol blue).
反応液中の大腸菌ファージ入 DNAを0.51.1g
1m4のエチジウムブロマイドを含ませたtXアガロー
スゲル電気泳動にて分離し、υV熱照射DNAの/ヘン
ドの数と量が変化しなくなったときを終点とした。0.51.1g of Escherichia coli phage DNA in the reaction solution
It was separated by tX agarose gel electrophoresis containing 1 m4 of ethidium bromide, and the end point was when the number and amount of /Hend of the υV heat-irradiated DNA stopped changing.
上記反応において 114%入 DNAを完全に切断す
る酵素活性を1単位とした。In the above reaction, the enzyme activity that completely cleaves 114% DNA was defined as one unit.
[実施例]
クロストリジウム・コッコイデスB−2(微工研菌寄第
11238号)はスチールジャー及びカザミノ酸液体培
地(表1)を用いて嫌気培養を行った。[Example] Clostridium coccoides B-2 (Feikoken Bibori No. 11238) was cultured anaerobically using a steel jar and a casamino acid liquid medium (Table 1).
前培養は37℃で24時間、本培養は前培養液を本培養
液の1/100量接種し、37℃で48時間行った。Preculture was carried out at 37°C for 24 hours, and main culture was carried out at 37°C for 48 hours by inoculating the preculture solution in an amount of 1/100 of the main culture solution.
遠心分離で菌体を集めたところ、約12gの湿菌体を得
た。When the bacterial cells were collected by centrifugation, about 12 g of wet bacterial cells were obtained.
表 1
カザミノ酸液体培地、 pH7,0(NaOH) 1
1カザミノ酸 4.0g酵母
エキス 3.0gポリペプトン
3・0gグルコース
10.Og堝化ナトリウム
1.58システイン塩酸 0.4g
得られた菌体7.Ogに緩衝液A(10mM )リス塩
酸、 pH7,5,10mM 2−メルカプトエタノー
ル。Table 1 Casamino acid liquid medium, pH 7.0 (NaOH) 1
1 Casamino acids 4.0g Yeast extract 3.0g Polypeptone
3.0g glucose
10. Og Sodium Sodium
1.58 Cysteine hydrochloric acid 0.4g
Obtained bacterial cells7. Buffer A (10mM) Lis-HCl, pH 7,5, 10mM 2-mercaptoethanol.
7IIM塩化マグネシウム)50IIQを加え、フレン
チプレスで細胞を破砕し、遠心分離で無細胞抽出液を得
た。7IIM magnesium chloride) 50IIQ was added, the cells were crushed with a French press, and a cell-free extract was obtained by centrifugation.
精製は以下の高速液体クロマトクラフィー(東ソー■製
)にて行なった。Purification was performed using the following high performance liquid chromatography (manufactured by Tosoh Corporation).
得られた無細胞抽出液を0.45μmのフィルターに通
した後、緩衝液B(10mM)リス塩酸。After passing the obtained cell-free extract through a 0.45 μm filter, buffer B (10 mM) was added to Lis-HCl.
pH7,5,7厘M2−メルカプトエタノール、 7m
M塩化マグネシウム)で平衡したDEAE−トヨパール
バック850M(イオン交換クロマトグラフィー)に吸
着させた。0〜400mMの塩化ナトリウムの直線的濃
度勾配を持つ緩衝MBで溶出させ、300mM塩化ナト
リウム濃度に制限酵素画分を得た。pH 7,5,7 M2-mercaptoethanol, 7m
It was adsorbed onto DEAE-Toyopearlvac 850M (ion exchange chromatography) equilibrated with Mgnesium chloride). Elution was performed with buffer MB having a linear concentration gradient of 0 to 400 mM sodium chloride to obtain a restriction enzyme fraction at a concentration of 300 mM sodium chloride.
得られた制限酵素画分を10%(V/V)グリセロール
を含む緩衝液Bに一夜透析した。この制限酵素画分を1
02(V/V)グリセロールを含む緩衝液Bで平衡した
TSKgel DEAE−5PW Glass(イオン
交換クロマトグラフィー)に吸着させ、また、0〜25
0■Hの直線的塩化ナトリウム濃度勾配を持つ緩衝液B
で溶出させて、120〜180mM塩化ナトリウム濃度
の制限酵素画分を得た。The obtained restriction enzyme fraction was dialyzed overnight against buffer B containing 10% (V/V) glycerol. This restriction enzyme fraction is
It was adsorbed on TSKgel DEAE-5PW Glass (ion exchange chromatography) equilibrated with buffer B containing 02 (V/V) glycerol.
Buffer B with a linear sodium chloride concentration gradient of 0 H
A restriction enzyme fraction with a sodium chloride concentration of 120 to 180 mM was obtained.
得られた制限酵素画分を10%(V/V)グリセロール
を含む緩衝液Bに一夜透析した。この制限酵素画分をl
og(V/V)グリセロールを含む緩衝液Bで平衡した
TSKgel Heparin−5PW Glass(
アフィニティークロマトグラフィー)に吸着させた。The obtained restriction enzyme fraction was dialyzed overnight against buffer B containing 10% (V/V) glycerol. This restriction enzyme fraction
TSKgel Heparin-5PW Glass (
Affinity chromatography).
O〜250+*Mの直線的塩化ナトリウム濃度勾配を持
つ緩衝液Bで溶出させて、40〜80mM塩化ナトリウ
ム濃度の制限酵素画分を得た。Elution was performed with buffer B with a linear sodium chloride concentration gradient of 0 to 250+*M to obtain a restriction enzyme fraction with a sodium chloride concentration of 40 to 80 mM.
この制限酵素画分を18倍に濃縮して、200+*M塩
化ナトリウム及びl0X(V/V)グリセロールを含む
緩衝液BにてTSKgel G3000SW Glas
s (ゲルろ過)に供した。This restriction enzyme fraction was concentrated 18 times and transferred to TSKgel G3000SW Glas in buffer B containing 200+*M sodium chloride and 10X (V/V) glycerol.
s (gel filtration).
リテンンヨンタイム12.0〜16.0分に°制限酵素
画分を得、最終酵素標品(960unit)を得た。A restriction enzyme fraction was obtained at a retention time of 12.0 to 16.0 minutes to obtain a final enzyme preparation (960 units).
ゲルろ過画分においては非特異的なりNA分解酵素及び
フォスファターゼは見られなかった。Nonspecific NA degrading enzyme and phosphatase were not observed in the gel filtration fraction.
[効 果]
上述した本発明によれば、従来使用されてきた制限酵素
に比べ、より幅広いpH安定性、及び温度安定性を有す
る新規制限酵素の簡便な工業生産法が可能となった。[Effects] According to the present invention described above, a simple industrial production method of a new restriction enzyme having a wider range of pH stability and temperature stability than conventionally used restriction enzymes has become possible.
Claims (3)
oI。 (a)作用及び基質特異性2本釦デオキシリボ核酸中の
塩基配列 5′−GCCGGC−3′ 3′−CGGCCG−5′ を認識し、かつこれを矢印の位置で切断する(式中、G
はグアノシン、Cはシチジンを示す)。 (b)至適pH8.0 (c)安定pH5.0〜10.0 (d)至適温度45℃ (e)安定温度70℃ 但し、5分間の加熱による。 (f)安定塩濃度50〜100mM 但し、塩化ナトリウムによる。 (g)分子量62,000 但し、ゲルろ過法による。(1) A novel restriction enzyme Cc having the following enzymatic chemical properties
oI. (a) Action and substrate specificity Recognizes the base sequence 5'-GCCGGC-3'3'-CGGCCG-5' in deoxyribonucleic acid and cleaves it at the position of the arrow (in the formula, G
indicates guanosine and C indicates cytidine). (b) Optimum pH 8.0 (c) Stable pH 5.0 to 10.0 (d) Optimum temperature 45°C (e) Stable temperature 70°C However, by heating for 5 minutes. (f) Stable salt concentration 50 to 100mM, however, based on sodium chloride. (g) Molecular weight: 62,000 However, by gel filtration method.
産菌を栄養培地で培養し、培養物より制限酵素CcoI
を採取することを特徴とする制限酵素CcoIの製造方
法。(2) Cultivate restriction enzyme CcoI-producing bacteria belonging to the genus Clostridium in a nutrient medium, and extract the restriction enzyme CcoI from the culture.
A method for producing a restriction enzyme CcoI, which comprises collecting the restriction enzyme CcoI.
産菌が、クロストリジウム・コッコイデスB−2である
特許請求の範囲第2項記載の製造方法。(3) The production method according to claim 2, wherein the restriction enzyme CcoI-producing bacterium belonging to the genus Clostridium is Clostridium coccoides B-2.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2041512A JPH03244381A (en) | 1990-02-21 | 1990-02-21 | New restriction enzyme and its production |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2041512A JPH03244381A (en) | 1990-02-21 | 1990-02-21 | New restriction enzyme and its production |
Publications (1)
Publication Number | Publication Date |
---|---|
JPH03244381A true JPH03244381A (en) | 1991-10-31 |
Family
ID=12610429
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2041512A Pending JPH03244381A (en) | 1990-02-21 | 1990-02-21 | New restriction enzyme and its production |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPH03244381A (en) |
-
1990
- 1990-02-21 JP JP2041512A patent/JPH03244381A/en active Pending
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US4493893A (en) | Process for cloning the gene coding for a thermostable alpha-amylase into Escherichia coli and Bacillus subtilis | |
EP0057976B1 (en) | a process for cloning the gene coding for a thermostable alpha-amylase into escherichia coli and bacillus subtilis | |
US5633138A (en) | Thermostable alkaline phosphatase of thermus thermophilus | |
US4420562A (en) | Method for producing creatinase | |
US4161424A (en) | Novel endonuclease and process for production thereof | |
Wilde et al. | Clostridium tetanomorphum sp. nov., nom. rev. | |
US4430432A (en) | Endo-deoxyribonuclease and process for the production thereof | |
US5061628A (en) | Restriction endonuclease FseI | |
JPH03244381A (en) | New restriction enzyme and its production | |
US4259446A (en) | Process for preparation of deoxyribonucleases | |
JPH03216188A (en) | New restriction enzyme and production thereof | |
RU2070925C1 (en) | Strain of bacterium escherichia coli - a producer of restriction endonuclease eco 71 ki | |
JPH03112484A (en) | Novel restriction enzyme and its production | |
JPH0458884A (en) | New restrictive enzyme | |
RU2044053C1 (en) | Strain of bacterium escherichia coli - a producer of restriction endonuclease eco27k1 | |
SU1761803A1 (en) | Strain of bacteria bacillus alvei - producer of restriction endonuclease bav bii | |
RU2053298C1 (en) | Strain of bacterium escherichia coli - a producer of restriction endonuclease eco 75 ki | |
SU908793A1 (en) | Strain escherichia coli b834 (r , m ) carrying rsf plasmide 2124-test-substrate for restrictive endonuclease ecor11 | |
JPH02283281A (en) | New restriction enzyme and production thereof | |
JPH03108486A (en) | Plasmid to code heparinase, heparinase producing strain having same plasmid and production of heparinase | |
SU1631081A1 (en) | Strain of bacteria coli rfl - producer of restrictase e co 1051 | |
RU2044054C1 (en) | Strain of bacterium escherichia coli - a producer of restriction endonuclease eco 110 ki | |
JPH0198484A (en) | Type 2 restriction endonuclease,obtain- ment thereof,and method for recog- nizing and cleaving complementary double-stranded dna sequence | |
JP2770030B2 (en) | Method for producing ketohexokinase | |
JP2602840B2 (en) | Plasmids and Escherichia coli transformed therewith |